These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 1362948)
21. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling. Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777 [TBL] [Abstract][Full Text] [Related]
22. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs. Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948 [TBL] [Abstract][Full Text] [Related]
23. The orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans. Denissen JF; Grabowski BA; Johnson MK; Boyd SA; Uchic JT; Stein H; Cepa S; Hill P Drug Metab Dispos; 1994; 22(6):880-8. PubMed ID: 7895605 [TBL] [Abstract][Full Text] [Related]
24. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans. Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226 [TBL] [Abstract][Full Text] [Related]
25. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects. Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs. Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512 [TBL] [Abstract][Full Text] [Related]
27. Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways. Dalvie DK; Khosla NB; Navetta KA; Brighty KE Drug Metab Dispos; 1996 Nov; 24(11):1231-40. PubMed ID: 8937858 [TBL] [Abstract][Full Text] [Related]
29. Metabolic disposition of the cognition activator tacrine in rats, dogs, and humans. Species comparisons. Pool WF; Reily MD; Bjorge SM; Woolf TF Drug Metab Dispos; 1997 May; 25(5):590-7. PubMed ID: 9152598 [TBL] [Abstract][Full Text] [Related]
30. Absorption, distribution, metabolism, and excretion of dirlotapide in the dog. Merritt DA; Bessire AJ; Vaz AD; Sams JP; Lynch MP J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():17-23. PubMed ID: 17567511 [TBL] [Abstract][Full Text] [Related]
31. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs. Vickers S; Duncan CA; Slaughter DE; Arison BH; Greber T; Olah TV; Vyas KP Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219 [TBL] [Abstract][Full Text] [Related]
32. Metabolism of an anxiolytic imidazobenzodiazepine by the dog. Kolis SJ; Postma EJ; Williams TH; Sasso GJ; Schwartz MA Drug Metab Dispos; 1983; 11(4):324-8. PubMed ID: 6137338 [TBL] [Abstract][Full Text] [Related]
33. The metabolism and excretion of carbovir, a carbocyclic nucleoside, in the rat. Walsh JS; Patanella JE; Unger SE; Brouwer KR; Miwa GT Drug Metab Dispos; 1990; 18(6):1084-91. PubMed ID: 1981517 [TBL] [Abstract][Full Text] [Related]
34. Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs. He H; Tran P; Yin H; Smith H; Flood D; Kramp R; Filipeck R; Fischer V; Howard D Drug Metab Dispos; 2009 Mar; 37(3):545-54. PubMed ID: 19074976 [TBL] [Abstract][Full Text] [Related]
35. Comparative theobromine metabolism in five mammalian species. Miller GE; Radulovic LL; DeWit RH; Brabec MJ; Tarka SM; Cornish HH Drug Metab Dispos; 1984; 12(2):154-60. PubMed ID: 6144479 [TBL] [Abstract][Full Text] [Related]
36. Metabolism and excretion of imrecoxib in rat. Xu H; Zhang Y; Sun Y; Zhang P; Chu F; Guo Z; Zhang H; Zhong D Xenobiotica; 2006 May; 36(5):441-55. PubMed ID: 16854781 [TBL] [Abstract][Full Text] [Related]
37. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
38. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs. Prakash C; Cui D; Potchoiba MJ; Butler T Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205 [TBL] [Abstract][Full Text] [Related]
39. Identification of the main urinary metabolites of omeprazole after an oral dose to rats and dogs. Hoffmann KJ Drug Metab Dispos; 1986; 14(3):341-8. PubMed ID: 2872036 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic study of [14C]flutrimazole after oral and intravenous administration in dogs. Comparison with clotrimazole. Conte L; Ramis J; Mis R; Vilageliu J; Basi N; Forn J Arzneimittelforschung; 1992 Jun; 42(6):854-8. PubMed ID: 1418045 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]